Steven Cohen Cytokinetics Inc Put Options Transaction History

Point72 Asset Management, L.P.

  • $36 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$47.86 - $75.05 $957,200 - $1.5 Million
20,000 New
20,000 $1.08 Million
Q4 2023

Feb 14, 2024
BUY
$26.88 - $83.49 $4.84 Million - $15 Million
180,000 Added 450.0%
220,000 $18.4 Million
Q3 2023

Nov 14, 2023
BUY
$29.46 - $36.61 $1.18 Million - $1.46 Million
40,000 New
40,000 $1.18 Million

Others Institutions Holding CYTK

# of Institutions
403
Shares Held
126M
Call Options Held
3.27M
Put Options Held
2.01M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $5.26B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email